Adaptive diversity of innate immune receptor family short pentraxins in Murinae  by Li, Yan et al.
FEBS Letters 586 (2012) 798–803journal homepage: www.FEBSLetters .orgAdaptive diversity of innate immune receptor family short pentraxins in Murinae
Yan Li a,⇑, Judith H. Robins b, Jianping Ye c, Zhiyong Huang d, Qiang Wen a, Guojie Zhang d,⇑
aCollege of Animal Science and Technology, Sichuan Agriculture University, Yaan, Sichuan 625014, PR China
b School of Biological Sciences & Department of Anthropology, The University of Auckland, Private Bag 92019, Auckland, New Zealand
cCollege of Life Sciences, Shaoxing University, Shaoxing, Zhejiang 312000, PR China
dBGI-Shenzhen, Shenzhen 518083, PR China
a r t i c l e i n f o a b s t r a c tArticle history:
Received 14 November 2011
Revised 20 January 2012
Accepted 23 January 2012
Available online 1 February 2012






Murinae0014-5793/$36.00  2012 Federation of European Bio
doi:10.1016/j.febslet.2012.01.048
Abbreviations: CRP, C-reactive protein; SAP, ser
dN, the number of non-synonymous substitutions per
number of synonymous substitutions per synonymou
⇑ Corresponding authors. Fax: +86 835 2886080.
E-mail addresses: liyan@sicau.edu.cn (Y. Li
(G. Zhang).The short pentraxins C-reactive protein (CRP) and serum amyloid P component (SAP) constitute a
group of innate immune receptors that trigger immune activation by detecting molecules of the
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The innate immune system is the ﬁrst line of host defense
against pathogens and is critical in activating and orienting adap-
tive immunity. The recognition of pathogens by receptors is the
principle aspect of the innate immune system. The innate immune
system recognizes pathogens through germline-encoded pattern
recognition receptors (PRRs) [1].
Pentraxins are a superfamily of innate immune receptors charac-
terized as having ﬁve or ten identical subunits, which are arranged
in pentameric symmetry [2]. Based on the length of the subunits,
the pentraxins are divided into two groups: long pentraxins and
short pentraxins. PTX3 together with PTX4, NP1, NP2, and NPR con-
stitute the long pentraxins. The short pentraxins include two mem-
bers: CRP and SAP. CRP was the ﬁrst pentraxin characterized in the
1930s and named for its ability to bind in a Ca2+-dependent manner
the C-polysaccharide of Streptococcus pneumoniae. Human SAP was
subsequently identiﬁed as a relative of CRP because of the amino
acid sequence similarity (51%) between them [3,4].chemical Societies. Published by E
um amyloid P component;
non-synonymous site; dS, the
s site
), zhanggj@genomics.org.cnThe crystal structures of human CRP and SAP have been deter-
mined, supporting that they are related [2,5,6]. The subunit (pro-
tomer) consists of a two-layered, antiparallel b sheet and a
single, short a-helix with a ﬂat topology. One face, designated A,
is characterized by the presence of a furrow. Mutagenesis studies
have demonstrated that certain residues in the furrow of CRP make
contact with C1q [7–9] and the IgG receptors FccRI (CD64) and
FccRII (CD32) [10–13]. The other face, designated B, contains a
ligand-binding concave face. The ligand-binding site consists of
several residues that form a hydrophobic pocket and two Ca2+ ions
[14,15]. The contact domain between subunits comprises the
open-core end of the two-layered b sheet of one protomer and
the N- and C-terminal strands of another [16].
Short pentraxins recognize ligands and protect against various
pathogens, including parasites, fungi, yeasts, and bacteria
[17–19]. The direct interaction between CRP and phosphorylcho-
line (PC) mediates its binding to several microorganisms, including
the C-polysaccharide of pneumococcus [20], the lipopolysaccha-
ride (LPS) of Hemophilus inﬂuenzae [21], and the repeating phos-
phorylated disaccharide of Leishmania donovani [22]. Moreover,
CRP binds carbohydrates on the surface of Plasmodium falciparum,
Hymenolepis diminuta, and L. donovani in a Ca2+-dependent manner
[23–26]. Like CRP, SAP recognizes various microorganisms, such as
Streptococcus pyogenes, Neisseria meningitidis, and the inﬂuenza
virus [27–29]. The ligands for SAP include core polysaccharide moi-
eties of bacterial LPS and phosphoethanolamine (PE) and chemicallsevier B.V. All rights reserved.
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pentraxins initiates a series of innate immune reactions, such as
the activation of the classical complement pathway [33,34] and
the stimulation of macrophages [12,13,35–38].
Pentraxins are generally regarded as a superfamily of evolution-
arily conserved proteins characterized by their structural and
physiological role in organisms. However, many previous studies
have suggested that pathogens have evolved a range of anti-
immune molecular mechanisms to overcome both innate and
adaptive immunity [39]. In the case of the short pentraxins, there
are conﬂicting reports of a possible protective role of CRP toward
ligands. In the in vivo plasma clearance experiment, pneumococcal
C-polysaccharide (CPS) a ligand to which CRP binds, was not
cleared immediately in rats, indeed the half-life of the ligand was
rather slower than it was in mice [40]. In another study, passively
administered mouse CRP is unable to provide protection against
the lethal toxicity of LPS [41]. In contrast to this, rabbit (Oryctolagus
cuniculus) CRP expressed in mice is able to modulate a transgenic
line to be resistant to the lethal effect of bacterial LPS [42]; and
similarly, human CRP administration is protective in some experi-
mental models [29,43]. Thus, determining the evolution of this
gene family may be valuable in exploring the strategies by which
hosts and pathogens compete in the arms race. To investigate the
evolutionary process of short pentraxins in detail, we analyzed
the nucleotide variation patterns of these receptors among Rattus
norvegicus, Mus musculus and eight other species. This study might
shed some light on the strategies of short pentraxins in the arms
race between hosts and pathogens.
2. Materials and methods
2.1. Samples
To provide comprehensive information about the evolutionary
patterns and processes of CRP and SAP in Murinae, we collected
animals from nine species (Apodemus agrarius, A. draco, M. caroli,
M. pahari, Niviventer cremoriventer, R. exulans, R. norvegicus,
R. rattus, R. tanezumi). The sequences ofM. musculus were obtained
from GenBank (see below). The diversiﬁcation events of these spe-
cies have occurred between 12 and less than 0.3 My ago (Fig. S1).
The species names and registry numbers are presented in Table S1.
2.2. Sequence and alignment
The entire CRP and SAP coding region of all samples was ampli-
ﬁed from genomic DNA using primers in the conserved 50 UTR and
30 UTR regions. For CRP, the primers were: forward 50-CTTAG
TCCRGATCCCAGCAG-30 and reverse 50-CTCTAGTGCTGAGGACC-
ACA-30; for SAP, the primers were: forward 50-GCTGC TGCTGTCA-
TACCCTG-30 and reverse 50-AGGATTTTTATTTGGCAGATATG-30. The
PCR products were puriﬁed and cloned using the pMD 19-T Vector
kit (TaKaRa). The inserts were sequenced using the vector primer.
The sequences of a laboratory M. musculus strain (strain C57BL/6)
and R. norvegicus (strain Sprague–Dawley), obtained from GenBank
were used. Additional sequences of CRP and SAP genes in 32
individuals from ﬁve species (n = 10 R. norvegicus, 4 R. tanezumi,
10 A. agrarius, 4 N. cremoriventer, and 4 M. caroli) were determined
with the same method, and the resulting sequences were aligned
using ClustalW [44] and checked manually. The accession numbers
of sequences are presented in Table S1.
2.3. Evolutionary analysis
To examine positive and negative selectionwithin short pentrax-
ins during Murinae evolution, we ﬁrst analyzed the substitutionpatterns between pairs of species. Combining the sequences of
M. musculus and R. norvegicus, we calculated the ratios of the num-
ber of non-synonymous substitutions per non-synonymous site (dN)
and the number of synonymous substitutions per synonymous site
(dS) for each coding region using Pamilo-Bianchi-Li’s method [45].
The Z-test was used to detect deviations of dN/dS from neutrality.
After detecting adaptive selection in the coding regions, we
examined positive selection at individual sites in the data set pre-
viously used in evaluating substitution patterns between species
pairs (Table S1) with CODEML in the PAML package [46,47]. We
implemented three pairs of models: M0 versus M2, M7 versus
M8, and M8a versus M8, generating two likelihood ratios. M0,
M7, and M8a assumed that all codons evolved neutrally or under
purifying selection (dN/dS values 6 1); M2 and M8 allowed a pro-
portion of sites to be under positive selection with dN/dS > 1. In
all tests, a likelihood ratio test (LRT) was used to compare the
two models [48,49]. With the same maximum likelihood approach,
we then analyzed allelic datasets of CRP and SAP from R. norvegicus
and A. agrarius to assess whether positive selection had inﬂuenced
the variation within species.
2.4. Modeling
Because no crystal structure of murine pentraxins have to
date been reported, we simulated their tertiary structure with SWISS-
MODEL (Automated Protein Modeling Server http://swissmodel.
expasy.org/) [50,51]. The tertiary structure conﬁdence (QMEAN4
Z-score) was assessed using Structure Assessment.
3. Results and discussion
3.1. The short pentraxins share the same gene structures in Murinae
lineages
The molecular signature of adaptive selection can be identiﬁed
through comparative sequence analysis among species. We ampli-
ﬁed short pentraxin genes in eight species and cloned the products
into vectors. One clone per species was sequenced and used to
disclose the evolutionary patterns of the short pentraxin family in
Murinae. The sequences had the same gene structures as CRP and
SAP inM.musculus and R. norvegicus, based on their Ensembl entries.
3.2. Adaptive selection could have effects on the evolution of short
pentraxins in Murinae lineages
Because the continual challenge posed by pathogenic diseases
undoubtedly played an essential role in shaping the variation of
present-day host immune systems, we analyzed the sequence vari-
ations in the entire coding region of CRP and SAP in these Murinae
species. Across the CRP and SAP data sets, we observed a large
number of non-synonymous substitutions. In the possible pairwise
comparisons, the dN/dS ratios of CRP and SAPwere calculated. For the
CRP sequences, we observed that dN exceeded dS in R. norvegicus ver-
susN. cremoriventer (P = 0.039) and R. exulans versusN. cremorivent-
er (P = 0.046) signiﬁcantly. Further, the dN/dS ratios of R. rattus
versusN. cremoriventer, R. tanezumi versusN. cremoriventer,M. caroli
versus N. cremoriventer, and A. agrarius versus A. draco exceeded 1,
which deviated from neutral expectation.
For the SAP sequences, using the Z-test, none of the pairwise
comparison ratios exceeded one signiﬁcantly. However, the ratios
of N. cremoriventer to R. norvegicus, R. rattus, and R. tanezumi were
similar to that of CRP, for which dN/dS > 1. In addition, the dN/dS
ratios between M. pahari and Rattus greatly exceeded 1. These
observations suggest that short pentraxins experienced Darwinian
positive selection in Murinae lineages.
Table 1
Likelihood values and sites inferred to be under positive selection for short pentraxins genes across Murinae lineages.
Gene Model l 2DL Sites under selection identiﬁed by PAML
CRP
M0: one-ratio 2225.62 41.70⁄⁄ (M2 versus M0) None
M2: selection 2204.77 32 65 90 213 214 (at 0.95 > PP 0.9)
8 76 164 (at 0.9 > PP 0.8)
M7: beta 2209.90 10.24⁄⁄ (M8 versus M7) Not allowed
M8a: beta & ﬁxed x 2209.86 10.16⁄⁄ (M8 versus M8a) Not allowed
M8: beta & x 2204.78 32 65 76 90 213 214 (at PP 0.95)
8 164 (at 0.95 > PP 0.9)
47 79 88 93 102 104 141 167 168 210 216 (at 0.9 > PP 0.8)
SAP
M0: one-ratio 2005.76 70.40⁄⁄ (M2 versus M0) None
M2: selection 1970.56 26 159 (at PP 0.99)
45 108 198 (at PP 0.95)
105 (at 0.95 > PP 0.9)
9 25 167 187 (at 0.9 > PP 0.8)
M7: beta 1983.83 26.46⁄⁄ (M8 versus M7) Not allowed
M8a: beta & ﬁxed x 1983.78 26.36⁄⁄ (M8 versus M8a) Not allowed
M8: beta & x 1970.60 26 159 198 (at PP 0.99)
25 45 105 108 (at PP 0.95)
167 187 194 (at 0.95 > PP 0.9)
9 97 112 141 147 191 (at 0.9 > PP 0.8)
Note. 2DL, twice the log likelihood difference between pair of models. Double asterisks correspond to P < 0.01 (one-tailed t-test). The numbers of amino acid sites represent
their position in the interspecies sequences alignment.
Table 2
The amino acid substitutions at the adaptively selected sites of CRP and SAP across
Murinae lineages.
Gene Position aa 1 aa 2 aa 3 aa 4 aa 5
CRP
32 Gly Glu Lys Thr
65 Val Ile Ala
76 Lys Thr Glu Asn
90 Gln Glu Lys
213 Thr Ala Lys Val
214 His Gln Arg Trp
SAP
25 Asn Asp Lys Tyr
26 Gln Trp Lys Arg Ser
45 Trp His Arg
105 Leu Lys Arg Met Ile
108 Phe Tyr Pro His
159 Thr Ser Ala Asn
198 Pro Leu Val Ile
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provide information about evolutionary patterns and processes
acting over different timescales [52–54], we performed an allelic
comparison of DNA sequence polymorphisms. We sequenced the
coding region of CRP and SAP of 32 individuals per gene from ﬁve
species (n = 10 R. norvegicus, 4 R. tanezumi, 10 A. agrarius, 4 N.
cremoriventer, and 4 M. caroli). Notably, CRP and SAP harbored
polymorphisms shared by different species (Fig. S1), with two
amino acid-altering polymorphisms in each gene.
There are several possible sources that could account for the
existence of interspeciﬁc shared polymorphisms, such as mainte-
nance of trans-species polymorphisms, convergent evolution, and
persistence of polymorphisms in recently diverged species. It is
feasible that the same polymorphisms detected between any two
species may have developed by chance when the species were
young. Because some of these polymorphisms are present in both
Rattus and Apodemus (Fig. S1), they have persisted in each species
since their divergence 12–24 million years ago [55,56], strongly
suggesting that the occurrence of such polymorphisms in these
two genes is not due to an exceptionally young age of the species.
Because of the long time since divergence of these species from
their common ancestor, it is difﬁcult to decide between the role ofconvergent evolution and trans-species polymorphisms. The long-
term maintenance of trans-species polymorphisms could be due to
balancing selection, as shown for the major histocompatibility
complex genes in jawed vertebrates [57–61]. Convergent change
is common at amino acid sites that have been inﬂuenced by either
positive selection [62–65] or relaxation of negative selection over
long periods of time. In order to detect the evolutionary forces in
this situation, we analyzed the within-species nucleotide variation
in R. norvegicus and A. agrarius (see below).
Adaptive evolution typically occurs at few sites, as most amino
acids in a protein are under functional constraints [45]. Using a
codon-based test in a maximum likelihood framework [46,47],
we narrowed down the individual sites that were under positive
selection in CRP and SAP during Murinae evolution. We compared
three pairs of models with and without positive selection using
likelihood ratio tests, and found that in each comparison, the mod-
el that includes sites with dN/dS > 1 ﬁts the data signiﬁcantly better
than the neutral one for both genes (Table 1). Both genes contained
several sites for which dN/dS > 1 (Table 1). Six sites in CRP and seven
sites in SAP had dN/dS ratios that rejected a neutral expectation in
favor of adaptive selection (PP 0.95).
With the allelic datasets of CRP and SAP from R. norvegicus and
A. agrarius, we repeated maximum likelihood analyses to assess
whether positive selection had inﬂuenced the variation within spe-
cies. For each of the genes, the proportion of sites under selection
was relatively low (Table S2). However, three interspeciﬁc shared
polymorphism sites showed dN/dS > 1 with a posterior probability
of 0.8. These results suggested that natural selection played an
important role in shaping these polymorphisms.
It is notable that some of the indicated amino acid changes at
these sites are radical in terms of their striking physicochemical
properties (Table 2). We used Grantham’s distance, which relies
on size, polarity, and carbon composition of amino acid side chains,
to measure the underlying physicochemical differences between
the exchanging residues [66]. Based on Grantham’s distance, an
amino acid substitution can be classiﬁed as either conservative or
radical. Several amino acid changes at these sites were radical,
strengthening the argument for a model of adaptive selection. For
the M. musculus/R. norvegicus comparison, there were 4 putative
selected sites in CRP that were different, of which the change at site











































Fig. 1. Stick model showing the locations of adaptively selected amino acid sites in short pentraxins. The positions of adaptively selected amino acids are shown on the
predicted three-dimensional structures of R. norvegicus CRP (A and B) and SAP (C and D) pentamers in red. (A and C): bottom view of the concave face for ligand-binding and
nearby selected residues (65, 76, and 90 of CRP in (A); 105, 108, and 159 of SAP in (C)). (B and D): side view of the selected amino acids. In each case, the surfaces that associate
to form a pentamer and contain sites under selection are shown in the squares. There are 21 amino acids missing in CRP and 20 amino acids missing in SAP compared with the
template.
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Similarly, all seven selected sites in SAP varied betweenM.musculus
and R. norvegicus, of which the substitution at site 45 (45His in M.
musculus and 45Trp in R. norvegicus, Grantham’s distance: 115)
was radical. Overall, these evolutionary changes in CRP and SAP
might have contributed to the functional divergence of these innate
immune receptors in murine species.
3.3. Sites under adaptive selection are located on the ligand-binding
and subunit interaction region of the short pentraxins
To gain insight into the structural and functional signiﬁcance of
the sites with evidence of selection, we located them on the three-
dimensional structures of CRP and SAP. The Murinae short pentrax-
ins shared the greatest similarity with human CRP (PDB ID: 1b09C)
and SAP (PDB ID: 3kqrB) proteins. Pairwise alignments of targets
against their templates showed that they share high sequence
identity (greater than 60%) (Fig. S2), which conﬁrmed that the
determined structures of the templates could be used for model-
ing. The reliability of modeling was assessed, and the resulting
QMEAN4 Z-scores (1.22 and 0.83, respectively) ensured that
the predicted structures were valid [67].On mapping the putatively selected sites onto the structural
models of CRP and SAP (Fig. 1), we observed that they fall in
disparate functional domains. One group of sites (65, 76, and 90)
is located on the side walls of the concave face on face B in CRP,
as are the sites 105, 108, and 159 in the corresponding domain
of SAP (Fig. 1A and C). It has been reported that the major interac-
tion of CRP with PC occurs between the phosphate group and
bound calcium ions in the center of the concave face [6,14–16].
The remaining portion of the PC molecule extends from the center
and runs along the surface of CRP [16]. The position of PC on the
LPS affects the susceptibility to CRP inH. inﬂuenzae [68]. In addition
to PC, short pentraxins bind to a wide variety of carbohydrates on
microbial surfaces [19]. Thus, the distribution of variable sites in
the side walls of the concave face may help to diversify the patho-
genic selectivity of short pentraxins, allowing them to recognize
disparate ligands. In a comparison of the CPR sequences, we found
that the residues at positions 65 and 90 in M. musculus differed
from those in R. norvegicus (Fig. S3), which could contribute to
the different plasma clearance rate of CPS in these species [40].
Further, comparing the CRP sequences ofM. musculus,Homo sapiens,
and O. cuniculus, we found that O. cuniculus and H. sapiens share the
same residues at position 65 and 90, which are different from that
802 Y. Li et al. / FEBS Letters 586 (2012) 798–803of M. musculus (Fig. S3). The differences among these residues are
consistent with the phenomenon that the CRPs from M. musculus
and the two other species provide the innate immune system’s
distinct speciﬁcity to LPS [29,41–43].
Another group of sites: 23, 32, 142, 213, and 214 in CRP and
sites 25, 26, 45, 198, and 207 in SAP, lie in the interaction region
of the protomer (Fig. 1B and D). In particular, sites 142 and 214
of Murinae CRP corresponded to sites 123 and 197 in the human
ortholog, which form an intermolecular ion pair [16]. Two sites
adopt different strategies: the shared polymorphisms (Lys and
Glu) in site 142 presented striking physicochemical properties,
and rapid changes at site 214 overlapped basic, non-polar, and un-
charged polar residues. Interestingly, with regard to site 14 in the
N-terminus of SAP, all four interspeciﬁc shared polymorphism sites
fell in the interaction region (Fig. S1 and Fig. 1). In addition, amphi-
pathic amino acids appeared frequently at these sites. One poten-
tial explanation for this is that the coexistence of polymorphisms
and the frequent presence of amphipathic amino acids provide
greater physicochemical variability for interacting residues in the
adjacent protomer. Because the structural organization of protom-
ers could play an important role in the activation of complement
pathway [16,69], it is possible that such conversions constitute a
functional adaptation that counters microbial insults that block
the interaction between protomers [39]. Future functional studies
are needed to determine the effects of these amino acid variations.
If the hypothesis is supported, it might reveal more insights into
the mechanism of the arms race between hosts and pathogens,
as well as the coevolution of proteins and their endogenous inter-
action partners.
The above analysis provides evidence that adaptive selection
drove the diversiﬁcation at a number of sites, which were distrib-
uted on the different functional domains of short pentraxins.
Understanding the evolution of these immune receptors in
Murinae could provide important insights regarding the physiolog-
ical function of these receptors and the mechanisms of the arms
race between host immune systems and diverse pathogens.
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